CME Group Inc. $CME Shares Purchased by BI Asset Management Fondsmaeglerselskab A S

BI Asset Management Fondsmaeglerselskab A S raised its stake in shares of CME Group Inc. (NASDAQ:CME) by 90.5% during the first quarter, Holdings Channel.com reports. The institutional investor owned 70,023 shares of the financial services provider’s stock after buying an additional 33,260 shares during the period. BI Asset Management Fondsmaeglerselskab A S’s holdings in CME Group were worth $20,681,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the stock. West Family Investments Inc. boosted its stake in shares of CME Group by 1.2% during the third quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock valued at $827,000 after acquiring an additional 37 shares during the last quarter. Asset Dedication LLC raised its stake in CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 37 shares during the last quarter. Northwestern Mutual Investment Management Company LLC raised its stake in CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock valued at $3,147,000 after purchasing an additional 37 shares during the last quarter. Rehmann Capital Advisory Group lifted its holdings in CME Group by 4.3% in the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after purchasing an additional 37 shares in the last quarter. Finally, 1248 Management LLC lifted its holdings in CME Group by 26.8% in the 3rd quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock valued at $49,000 after purchasing an additional 38 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ:CME opened at $246.38 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $89.28 billion, a price-to-earnings ratio of 21.02, a PEG ratio of 2.75 and a beta of 0.21. The stock’s 50-day moving average price is $279.61 and its two-hundred day moving average price is $287.21. CME Group Inc. has a 12-month low of $244.56 and a 12-month high of $329.16.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, beating analysts’ consensus estimates of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company’s quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.80 EPS. On average, research analysts forecast that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date is Tuesday, June 9th. CME Group’s payout ratio is presently 44.37%.

Analysts Set New Price Targets

Several research firms have issued reports on CME. Weiss Ratings cut shares of CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, June 11th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of CME Group from $342.00 to $322.00 and set a “buy” rating for the company in a research report on Thursday, April 23rd. Jefferies Financial Group reduced their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a research note on Thursday, April 9th. The Goldman Sachs Group decreased their target price on shares of CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research report on Thursday, April 23rd. Finally, TD Cowen cut their price target on CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a report on Thursday, April 23rd. Twelve equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $305.18.

CME Group News Roundup

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME continues to be highlighted as a dividend and value stock, with analysts noting its strong capital returns, electronic trading growth, and global product expansion could support a long-term rebound. Article Title
• Positive Sentiment: One market note said CME may be undervalued after the CEO succession announcement, suggesting the stock could have upside if investors view the leadership transition as orderly. Article Title
• Neutral Sentiment: CME named longtime finance chief Julie Winkler as its next CEO, while Terry Duffy will step into an executive chairman role; the move appears planned and may reduce uncertainty, but it also marks a major leadership change. Article Title
• Neutral Sentiment: The company is also taking legal action against the CFTC over approval of perpetual crypto futures, arguing the products should be treated as swaps rather than futures. The case could affect CME’s role in crypto derivatives, but the financial impact is still uncertain. Article Title
• Negative Sentiment: Goldman Sachs kept a Sell rating on CME and trimmed its price target, citing leadership transition risk and regulatory uncertainty, which may be weighing on sentiment. Article Title

Insider Buying and Selling

In related news, insider Hilda Harris Piell sold 5,753 shares of the company’s stock in a transaction that occurred on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the transaction, the insider owned 27,702 shares of the company’s stock, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their position. The SEC filing for this sale provides additional information. 0.30% of the stock is currently owned by insiders.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.